FIDES-01, a phase II study of derazantinib in patients with unresectable intrahepatic cholangiocarcinoma (iCCA) and FGFR2 fusions and mutations or amplifications (M/A) Meeting Abstract
| Authors: | Javle, M. M.; Shaib, W. L.; Braun, S.; Engelhardt, M.; Borad, M. J.; Abou-Alfa, G. K.; Boncompagni, A.; Friedmann, S.; Gahlemann, C. G. |
| Abstract Title: | FIDES-01, a phase II study of derazantinib in patients with unresectable intrahepatic cholangiocarcinoma (iCCA) and FGFR2 fusions and mutations or amplifications (M/A) |
| Meeting Title: | 2020 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000530922700575 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.4_suppl.TPS597 |
| Notes: | Meeting Abstract: TPS597 -- Source: Wos |
